InvestorsHub Logo
Followers 40
Posts 3778
Boards Moderated 0
Alias Born 01/21/2014

Re: LionsTact post# 3912

Wednesday, 05/27/2020 9:23:19 PM

Wednesday, May 27, 2020 9:23:19 PM

Post# of 4860
Gilead Gets an Upgrade With Street Mulling Remdesivir Profit

May 26, 2020, Bloomberg

Results from a late-stage Gilead-run study in moderate patients are expected this week and Van Buren said he was “now even more convinced” the data would be positive. Goldman Sachs analysts, who rate Gilead a sell, also expect the next trial to show a benefit and assumes Gilead will seek to break-even on remdesivir “at a minimum.”

The company has said it may spend $1 billion on remdesivir this year and plans to make the medicine “accessible and affordable” for governments and patients.



https://www.bloomberg.com/news/articles/2020-05-26/gilead-gets-an-upgrade-with-street-mulling-remdesivir-profit





Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GILD News